Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
THC Biomed Intl. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
THC Biomed Intl's
is considered below, and whether this is a fair price.
Price based on past earnings
THC Biomed Intl's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as THC Biomed Intl has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
THC Biomed Intl
expected to grow at an
Unable to compare THC Biomed Intl's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare THC Biomed Intl's earnings growth to the Canada market average as no estimate data is available.
Unable to compare THC Biomed Intl's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if THC Biomed Intl is high growth as no earnings estimate data is available.
Unable to determine if THC Biomed Intl is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
THC Biomed Intl's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
THC Biomed Intl
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Shareholders Are Raving About How The THC Biomed Intl (CNSX:THC) Share Price Increased 344%
It seems likely some shareholders believe that THC Biomed Intl will significantly advance the business plan before too long. … Of course, if you time it right, high risk investments like this can really pay off, as THC Biomed Intl investors might know. … THC Biomed Intl is not the only stock insiders are buying.
What Kind Of Shareholders Own THC Biomed Intl Ltd. (CNSX:THC)?
With a market capitalization of CA$41m, THC Biomed Intl is a small cap stock, so it might not be well known by many institutional investors. … Check out our latest analysis for THC Biomed Intl CNSX:THC Ownership Summary, May 29th 2019 What Does The Institutional Ownership Tell Us About THC Biomed Intl? … Insider Ownership Of THC Biomed Intl The definition of company insiders can be subjective, and does vary between jurisdictions.
Read This Before Buying THC Biomed Intl Ltd. (CNSX:THC) Shares
So shareholders might well want to know whether insiders have been buying or selling shares in THC Biomed Intl Ltd. … THC Biomed Intl Insider Transactions Over The Last Year. … Over the last year, we can see that the biggest insider sale was by Co-Founder Jung Hee for CA$976k worth of shares, at about CA$1.00 per share
Are THC Biomed Intl Ltd's (CNSX:THC) Interest Costs Too High?
While small-cap stocks, such as THC Biomed Intl Ltd (CNSX:THC) with its market cap of CA$56m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … Evaluating financial health as part of your investment thesis is
How Financially Strong Is THC Biomed Intl Ltd (CNSX:THC)?
THC Biomed Intl Ltd (CNSX:THC) is a small-cap stock with a market capitalization of CA$153.75m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Pharmaceuticals companies,
THC Biomed Intl Ltd. produces and sells medical marijuana in Canada. It also conducts research and development of the products and services related to cannabis for medical purposes. The company was founded in 2012 and is headquartered in Kelowna, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.